Treatment of Depressed Adolescents with Physical Illness

患有身体疾病的抑郁青少年的治疗

• 批准号: 6653042
• 负责人: EVA M SZIGETHY
• 金额: $ 16.52万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-09-01 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6653042
• 关键词: adolescence (12-20); anxiety; behavioral /social science research tag; clinical research; clinical trials; cognitive behavior therapy; comorbidity; corticosteroids; family structure /dynamics; family therapy; functional ability; gastrointestinal disorder chemotherapy; gender difference; human subject; human therapy evaluation; inflammatory bowel diseases; longitudinal human study; major depression; neuropsychological tests; neuropsychology; patient oriented research; postdoctoral investigator; problem solving; questionnaires; social behavior

DESCRIPTION (provided by applicant): The identification and treatment of depressive disorders in adolescents with chronic physical illness is an understudied area. The purpose of this Mentored Patient-Oriented Research Development Award (K23) is to enable the candidate to become an independent clinical researcher in the area of innovative approaches to evaluation and treatment of depression in adolescents facing physical illnesses. The proposal will focus on patients with inflammatory bowel disease (IBD). The project will be conducted at Children's Hospital Boston (CHB), where a large population of adolescents with IBD is available. William R. Beardslee, MD, with expertise in depressive disorders and prevention, will serve as the primary mentor. John March, MD, MPH and John Weisz, PhD, experts in clinical psychiatric outcome research and psychotherapy interventions, will serve as co-sponsors. Research plan: The aims are: 1) Conduct randomized comparison trial of cognitive behavioral therapy (CBT) enhanced with physical illness narrative, family education, and social skills components (n=24) to standard of community care treatment (n=24) in depressed adolescents with IBD, and 2) Investigate underlying neurobehavioral changes in adolescents with depression and IBD. Career development plan: The training will emphasize skills necessary for conducting comparative clinical trials in the treatment of depression in adolescents with chronic physical illness and begin to explore underlying neurological mechanisms of the disease process. Didactic work in intervention research design and statistics, developmental psychopathology, and assessment of methodologies for biological and neurobehavioral correlates of treatment response will complement supervision by the program consultants. With a sound understanding of pathobiology and change mechanisms, the long-term goals of the candidate are to develop and evaluate cognitive-behavioral and pharmacological treatments for physically ill children and adolescents with depression and to investigate neurobiological correlates of treatment effect.

描述（由申请人提供）：识别和治疗抑郁症的青少年慢性身体疾病是一个欠研究的领域。 该指导以患者为导向的研究发展奖（K23）的目的是使候选人能够成为一名独立的临床研究人员，在面临身体疾病的青少年中评估和治疗抑郁症的创新方法领域。 该提案将重点关注炎症性肠病（IBD）患者。 该项目将在波士顿儿童医院（CHB）进行，那里有大量患有IBD的青少年。 William R.比尔兹利，医学博士，在抑郁症和预防方面的专业知识，将担任主要导师。 John March，MD，MPH和John Weisz，PhD，临床精神病学结果研究和心理治疗干预专家，将担任共同赞助商。 研究计划：其目标是：1）在患有IBD的抑郁青少年中进行认知行为疗法（CBT）与标准社区护理治疗（n = 24）的随机比较试验，所述认知行为疗法（CBT）增强了身体疾病叙述、家庭教育和社交技能成分（n =24），以及2）调查患有抑郁和IBD的青少年的潜在神经行为变化。 职业发展计划：培训将强调在治疗患有慢性身体疾病的青少年抑郁症方面进行比较临床试验所需的技能，并开始探索疾病过程的潜在神经机制。 在干预研究设计和统计，发展心理病理学，治疗反应的生物和神经行为相关的方法学评估的教学工作将补充由程序顾问的监督。 通过对病理生物学和变化机制的充分理解，候选人的长期目标是开发和评估患有抑郁症的身体疾病儿童和青少年的认知行为和药物治疗，并调查治疗效果的神经生物学相关性。